A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Clinical trials showed that the medication dampened pain as effectively as an opioid-based painkiller. And perhaps most importantly, suzetrigine does so without the same risk of addiction.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option. On January 30, the U.S. Food and Drug Administration approved suzetrigine for the ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

While it provides a long-awaited alternative to opioids and over-the-counter painkillers like ibuprofen, research suggests its effectiveness is modest compared to standard opioid treatments.

Behind the scenes of the Free Press' reporting on harm reduction and Amanda Florida has been at the center of the opioid crisis for years, with thousands of residents affected by addiction and ...